Portfolio Update

RNS Number : 3072O
Intl. Biotechnology Trust PLC
16 May 2018
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

 

 

Portfolio Update as at 30 April 2018

 

Net Assets

£217m

Net Assets per share

579p

Share price

556p

Total value of unquoted investments

£23m

Total number of portfolio companies

90

Dividend

4% of NAV per annum

 

Top Ten Quoted Investments

 

Company Name

% NAV

Celgene

6.0

Neurocrine

4.2

Biogen

4.2

Array

3.9

Sage

3.8

Genmab

3.8

Adamas

3.7

Regeneron

3.7

Morphosys

3.7

Vertex

3.5


-----------

Total

40.5

 

Geographical Allocation

% NAV

US & Canada

86

Europe & UK

14


-----------

Total

100

 

 

Quoted/Unquoted Allocation

% NAV

Quoted

91

Unquoted

9


-----------

Total

100

 

 

NAV % Market Cap

% NAV

Large Cap >USD10BN

35

Mid Cap =USD1-10BN

40

Small Cap <USD1BN

25


-----------

Total

100

 

 

NAV % by Therapeutic Areas

% NAV

Oncology

41

CNS

15

Rare diseases

12

Inflammation

6

Ophthalmology

6

Infectious Diseases

4

Metabolic

3

Medtech

2

Other

11


-----------

Total

100

 

                                        

 

 

BNP Paribas Secretarial Services Limited

Company Secretary

 

16 MAY 2018


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBDGDUCDBBGIL
UK 100

Latest directors dealings